Divi's Laboratories Limited (DIVISLAB.BO)
INR 5849.2
(0.02%)
INR 5849.2
(0.02%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 154.7 Billion INR | 7.14% |
| 2022 | 144.38 Billion INR | 7.96% |
| 2021 | 133.74 Billion INR | 24.14% |
| 2020 | 107.74 Billion INR | 26.22% |
| 2019 | 85.35 Billion INR | 6.19% |
| 2018 | 80.38 Billion INR | 18.46% |
| 2017 | 67.85 Billion INR | 10.19% |
| 2016 | 61.58 Billion INR | 25.63% |
| 2015 | 49.02 Billion INR | 11.85% |
| 2014 | 43.82 Billion INR | 18.12% |
| 2013 | 37.1 Billion INR | 18.22% |
| 2012 | 31.38 Billion INR | 13.86% |
| 2011 | 27.56 Billion INR | 21.18% |
| 2010 | 22.74 Billion INR | 22.38% |
| 2009 | 18.58 Billion INR | 20.06% |
| 2008 | 15.48 Billion INR | 31.35% |
| 2007 | 11.78 Billion INR | 39.73% |
| 2006 | 8.43 Billion INR | 29.97% |
| 2005 | 6.49 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 154.7 Billion INR | 0.0% |
| 2023 FY | 154.7 Billion INR | 7.14% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 142.83 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 144.38 Billion INR | 0.0% |
| 2022 FY | 144.38 Billion INR | 7.96% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 135.18 Billion INR | 0.0% |
| 2021 FY | 133.74 Billion INR | 24.14% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 114.39 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 133.74 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 107.74 Billion INR | 26.22% |
| 2020 Q4 | 107.74 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 95.24 Billion INR | 0.0% |
| 2019 FY | 85.35 Billion INR | 6.19% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 85.35 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 80.7 Billion INR | 0.0% |
| 2018 FY | 80.38 Billion INR | 18.46% |
| 2018 Q4 | 80.38 Billion INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 67.85 Billion INR | 10.19% |
| 2016 FY | 61.58 Billion INR | 25.63% |
| 2015 FY | 49.02 Billion INR | 11.85% |
| 2014 Q4 | 44.05 Billion INR | 0.0% |
| 2014 FY | 43.82 Billion INR | 18.12% |
| 2013 Q4 | 37.1 Billion INR | 0.0% |
| 2013 FY | 37.1 Billion INR | 18.22% |
| 2012 FY | 31.38 Billion INR | 13.86% |
| 2012 Q4 | 31.38 Billion INR | 0.0% |
| 2011 FY | 27.56 Billion INR | 21.18% |
| 2010 FY | 22.74 Billion INR | 22.38% |
| 2009 FY | 18.58 Billion INR | 20.06% |
| 2008 FY | 15.48 Billion INR | 31.35% |
| 2007 FY | 11.78 Billion INR | 39.73% |
| 2006 FY | 8.43 Billion INR | 29.97% |
| 2005 FY | 6.49 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Ajanta Pharma Limited | 46.38 Billion INR | -233.521% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -4116.744% |
| Sigachi Industries Limited | 6.94 Billion INR | -2128.604% |
| Bal Pharma Limited | 3.2 Billion INR | -4728.505% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -1227.776% |
| Medico Remedies Limited | 961.95 Million INR | -15981.867% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -10153.949% |
| Venus Remedies Limited | 6.26 Billion INR | -2367.974% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -2903.65% |
| Alpa Laboratories Limited | 1.82 Billion INR | -8371.063% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -606.052% |
| Shilpa Medicare Limited | 30.93 Billion INR | -400.129% |
| Aarti Drugs Limited | 24.32 Billion INR | -536.008% |
| Lupin Limited | 239.97 Billion INR | 35.534% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 65.677% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 47.167% |
| Windlas Biotech Limited | 6.26 Billion INR | -2370.433% |
| Suven Life Sciences Limited | 2.84 Billion INR | -5329.924% |
| Eris Lifesciences Limited | 70.48 Billion INR | -119.469% |
| Valiant Laboratories Limited | 3.42 Billion INR | -4414.32% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -287.318% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | -558.029% |
| Ipca Laboratories Limited | 111.01 Billion INR | -39.353% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -1174.438% |
| Achyut Healthcare Limited | 309.52 Million INR | -49880.292% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 81.899% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -1921.885% |
| RPG Life Sciences Limited | 5.12 Billion INR | -2916.359% |
| Mankind Pharma Limited | 119.63 Billion INR | -29.313% |
| Laurus Labs Limited | 83.87 Billion INR | -84.451% |
| Piramal Pharma Limited | 153.11 Billion INR | -1.033% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -3722.926% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | -2.716% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -140.009% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | -7.74% |
| Unichem Laboratories Limited | 31.69 Billion INR | -388.114% |
| Sequent Scientific Limited | 15.4 Billion INR | -904.295% |
| Novartis India Limited | 9.24 Billion INR | -1572.559% |
| Wanbury Limited | 3.43 Billion INR | -4403.729% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -586.309% |
| Wockhardt Limited | 76.49 Billion INR | -102.249% |
| Themis Medicare Limited | 5.66 Billion INR | -2631.206% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -7026.471% |
| Jubilant Pharmova Limited | 115.48 Billion INR | -33.957% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -442.729% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 60.079% |
| NATCO Pharma Limited | 69.06 Billion INR | -123.998% |
| Gufic Biosciences Limited | 10.92 Billion INR | -1315.964% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -589.271% |
| Ind-Swift Limited | 6.54 Billion INR | -2263.74% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -1847.48% |
| FDC Limited | 24.68 Billion INR | -526.801% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -8582.49% |
| Granules India Limited | 55.2 Billion INR | -180.204% |
| Medicamen Biotech Limited | 2.94 Billion INR | -5152.572% |
| Alkem Laboratories Limited | 155.74 Billion INR | 0.674% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -1335.027% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -32757.079% |
| Brooks Laboratories Limited | 904.45 Million INR | -17004.242% |
| Megasoft Limited | 3.65 Billion INR | -4127.935% |
| ZIM Laboratories Limited | 4.46 Billion INR | -3362.226% |
| Strides Pharma Science Limited | 58.39 Billion INR | -164.908% |
| Neuland Laboratories Limited | 18.32 Billion INR | -744.174% |
| Morepen Laboratories Limited | 12.93 Billion INR | -1096.253% |
| Hikal Limited | 24.87 Billion INR | -522.0% |
| Indoco Remedies Limited | 21.44 Billion INR | -621.303% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -499.125% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -6344.179% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -4539.735% |
| Hester Biosciences Limited | 6.62 Billion INR | -2235.634% |